Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P)+ transhydrogenase enzyme

US9850507B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9850507-B2
Application numberUS-201314416633-A
CountryUS
Kind codeB2
Filing dateJul 25, 2013
Priority dateJul 25, 2012
Publication dateDec 26, 2017
Grant dateDec 26, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.

First claim

Opening claim text (preview).

The invention claimed is: 1. A recombinant yeast cell engineered to produce succinate through an active reductive tricarboxylic acid (TCA) pathway from pyruvate or phosphoenolpyruvate to succinate, wherein the recombinant yeast cell is modified from a parent yeast cell by having integrated into its genome an exogenous gene encoding a soluble nicotinamide adenine dinucleotide phosphate (NAD(P)+) transhydrogenase enzyme, wherein the soluble NAD(P)+transhydrogenase enzyme is expressed in the cytosol of the recombinant yeast cell, wherein the recombinant yeast cell is further modified from the parent yeast cell by having integrated into its genome at least one of: (i) an exogenous pyruvate carboxylase gene that encodes an enzyme which catalyzes the conversion of pyruvate to oxaloacetate; (ii) an exogenous malate dehydrogenase gene which encodes an enzyme that catalyzes the conversion of oxaloacetate to malate; (iii) an exogenous fumarase gene that encodes an enzyme which catalyzes the conversion of malate to fumarate; and (iv) an exogenous fumarate reductase gene which encodes an enzyme which catalyzes the conversion of fumarate to succinate, and wherein the recombinant yeast cell produces more succinate through the active reductive TCA pathway as compared to the parent cell. 2. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is further modified from the parent yeast cell by having integrated into its genome at least one non-native malate dehydrogenase gene which encodes an enzyme that catalyzes the conversion of oxaloacetate to malate. 3. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is further modified from the parent yeast cell by having integrated into its genome at least one non-native fumarate reductase gene which encodes an enzyme which catalyzes the conversion of fumarate to succinate. 4. The recombinant yeast cell of claim 1 wherein the recombinant yeast cell is further modified from the parent yeast cell by having integrated into its genome at least one non-native 6-phosphogluconate dehydrogenase gene that encodes a 6-phosphogluconate dehydrogenase enzyme. 5. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is further modified from the parent yeast cell by having integrated into its genome at least one non-native glucose 6-phosphate dehydrogenase gene that encodes a glucose 6-phosphate dehydrogenase enzyme. 6. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is further modified from the parent yeast cell by having integrated into its genome at least one non-native Stb5p gene that encodes an Stb5p protein. 7. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is further modified from the parent yeast cell by having a deletion or disruption of a native phosphoglucose isomerase gene. 8. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is further modified from the parent yeast cell by having a deletion or disruption of a native pyruvate decarboxylase gene. 9. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is a yeast of the species Issatchenkia orientalis. 10. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is a yeast of the species: Candida sonorensis, Kluyveromyces marxianus, Kluyveromyces thermotolerana, Candida methanesobosa, Issatchenkia orientalis, Candida lambica, Candida sorboxylosa, Candida zemplinina, Candida geochares, Pichia membranifaciens, Zygosaccharomyces kombuchaensis, Candida sorbosivorans, Candida vanderwaltii, Candida sorbophila, Zygosaccharomyces bisporus, Zygosaccharomyces lentus, Saccharomyces bayanus, Candida boidinii, Candida etchellsii, Kluyvermyces lactis, Pichia jadinii , or Pichia anomala. 11. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell produces no more than 2% of the theoretical yield of ethanol. 12. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell exhibits a volumetric glucose consumption rate of at least 0.9 gram of glucose per liter of broth per hour when cultivated at 30° C. with shaking at 150 rpm for 96 hours in a 250 mL baffled shake flask containing 1.28 g/L dry CaCO 3 , 50 mL of shake flask medium which is a sterilized, 4.5 pH aqueous solution of urea (2.3 g/L), magnesium sulfate heptahydrate (0.5 g/L), potassium phosphate monobasic (3.0 g/L), trace element solution (1 mL/L), vitamin solution (1 mL/L), glucose (120.0 g/L), glycerol (0.1 g/L), and 2-(N-Morpholino) ethanesulfonic acid (MES) (4.0 g/L), wherein the trace element solution is an aqueous solution of EDTA (15.0 g/L), zinc sulfate heptahydrate (4.5 g/L), manganese chloride dehydrate (1.0 g/L), cobalt(II) chloride hexahydrate (0.3 g/L), copper(II)sulfate pentahydrate (0.3 g/L), disodium molybdenum dehydrate (0.4 g/L), calcium chloride dehydrate (4.5 g/L), iron sulphate heptahydrate (3 g/L), boric acid (1.0 g/L), and potassium iodide (0.1 g/L), and wherein the vitamin solution is an aqueous solution of biotin (D-; 0.05 g/L), calcium pantothenate (D+; 1 g/L), nicotinic acid (5 g/L), myo-inositol (25 g/L), pyridoxine hydrochloride (1 g/L), and paminobenzoic acid (0.2 g/L). 13. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell is further modified from the parent yeast cell by having a deletion or disruption of an endogenous glycerol-3-phosphate dehydrogenase gene. 14. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell has no deletion or disruption of an endogenous phosphoglucose isomerase gene and produces a native phosphoglucose isomerase enzyme. 15. The recombinant yeast cell of claim 14 , wherein the recombinant yeast cell is a yeast of the species Issatchenkia orientalis. 16. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell comprises integrated into its genome at least two of (i) to (iv). 17. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell comprises integrated into its genome at least three of (i) to (iv). 18. The recombinant yeast cell of claim 1 , wherein the recombinant yeast cell comprises integrated into its genome all of (i) to (iv).

Assignees

Inventors

Classifications

  • Pyruvate carboxylase (6.4.1.1) · CPC title

  • acting on CH-OH groups as donors (1.1) · CPC title

  • Cross-Sectional Technologies · mapped topic

  • polyhydric · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9850507B2 cover?
Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.
Who is the assignee on this patent?
Cargill Inc, Bioamber Inc
What technology area does this patent fall under?
Primary CPC classification C12P7/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).